IRVINE, Calif.--(BUSINESS WIRE)--CoreValve (www.corevalve.com), a medical device company developing technologies for percutaneous heart valve replacement, announced today that it received $33 million in funding in its third institutional round of financing. Maverick Capital led the round and was joined by existing investors Apax Partners, HealthCap, and Sofinnova Partners.
